BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24821606)

  • 1. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.
    Tanase-Nakao K; Naruse M; Nanba K; Tsuiki M; Tagami T; Usui T; Okuno H; Shimatsu A; Hashimoto S; Katabami T; Ogo A; Okumura A; Umakoshi H; Suzuki T
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):665-70. PubMed ID: 24821606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
    Kim IY; Park IS; Kim MJ; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH; Chung HC
    Int Urol Nephrol; 2018 Oct; 50(10):1887-1895. PubMed ID: 29779118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.
    Utsumi T; Kawamura K; Imamoto T; Nagano H; Tanaka T; Kamiya N; Nihei N; Naya Y; Suzuki H; Ichikawa T
    Int J Urol; 2013 Jul; 20(7):685-91. PubMed ID: 23190329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.
    Utsumi T; Kamiya N; Kaga M; Endo T; Yano M; Kamijima S; Kawamura K; Imamoto T; Ichikawa T; Suzuki H
    World J Urol; 2017 Oct; 35(10):1577-1583. PubMed ID: 28401356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
    Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
    J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.
    Kim DH; Kwon HJ; Ji SA; Jang HR; Jung SH; Kim JH; Kim JH; Lee JE; Huh W; Kim YG; Kim DJ; Oh HY
    Medicine (Baltimore); 2016 Jul; 95(27):e3930. PubMed ID: 27399066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism.
    Onohara T; Takagi T; Yoshida K; Iizuka J; Okumi M; Kondo T; Ishida H; Tanabe K
    Int J Urol; 2019 Feb; 26(2):229-233. PubMed ID: 30384394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is acute kidney injury after laparoscopic adrenalectomy related to the progression of chronic kidney disease in patients with primary aldosteronism?
    Yoon JH; Chung HS; Hong AR; Kim HK; Kang HC; Kim MS; Hwang EC; Jung SI; Park K; Kwon D
    Investig Clin Urol; 2021 Sep; 62(5):560-568. PubMed ID: 34387032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
    An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.
    Kaga M; Utsumi T; Tanaka T; Kono T; Nagano H; Kawamura K; Kamiya N; Imamoto T; Nihei N; Naya Y; Suzuki H; Ichikawa T
    World J Surg; 2015 Dec; 39(12):2935-40. PubMed ID: 26296835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
    Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney impairment in primary aldosteronism.
    Wu VC; Yang SY; Lin JW; Cheng BW; Kuo CC; Tsai CT; Chu TS; Huang KH; Wang SM; Lin YH; Chiang CK; Chang HW; Lin CY; Lin LY; Chiu JS; Hu FC; Chueh SC; Ho YL; Liu KL; Lin SL; Yen RF; Wu KD;
    Clin Chim Acta; 2011 Jul; 412(15-16):1319-25. PubMed ID: 21345337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical Versus Medical Management.
    Cohen DL; Wachtel H; Vaidya A; Hundemer GL; Tezuka Y; Davio A; Turcu AF; Cohen JB
    Hypertension; 2023 Oct; 80(10):2187-2195. PubMed ID: 37593884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.
    Terata S; Kikuya M; Satoh M; Ohkubo T; Hashimoto T; Hara A; Hirose T; Obara T; Metoki H; Inoue R; Asayama K; Kanno A; Totsune K; Hoshi H; Satoh H; Sato H; Imai Y
    J Hypertens; 2012 Aug; 30(8):1632-8. PubMed ID: 22595958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series.
    Tahir A; McLaughlin K; Kline G
    BMC Endocr Disord; 2016 Jul; 16(1):43. PubMed ID: 27460219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly.
    Takeda M; Yamamoto K; Akasaka H; Rakugi H; Naruse M; Takeda Y; Kurihara I; Itoh H; Umakoshi H; Tsuiki M; Ichijo T; Katabami T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Ogo A; Okamura S; Miyauchi S; Yanase T; Suzuki T; Kawamura T;
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3620-3629. PubMed ID: 30099522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
    Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort.
    Worth PJ; Kunio NR; Siegfried I; Sheppard BC; Gilbert EW
    Am J Surg; 2015 Oct; 210(4):702-9. PubMed ID: 26323999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Treating Primary Aldosteronism on Renal Function.
    Kramers BJ; Kramers C; Lenders JW; Deinum J
    J Clin Hypertens (Greenwich); 2017 Mar; 19(3):290-295. PubMed ID: 27659389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.